The emergence of COVID-19 has significantly affected global health, prompting an urgent need read more for effective treatments. Medical professionals have been tirelessly working to develop new therapies, and recently, a promising antiviral drug called Molnupiravir has gained traction. This oral medication has shown promise in treating mild to mod

Linaclotide, generally prescribed for persistent idiopathic constipation and irritable bowel syndrome with constipation (IBS-C), represents a novel approach to gastrointestinal health. This GC-C agonist works directly within the intestines to boost fluid secretion and expedite bowel movements. Unlike standard laxatives that primarily act on the col